Archive for Medication updates
Class 2 Medicines Recall: Various Marketing Authorisation Holders and parallel distributor companies, Irbesartan-containing products, EL(21)A/34
Source: MHRA Gov.uk 1/12/21 Specific batches of products supplied by Marketing Authorisation Holders and parallel distributor companies are being recalled due to presence of a mutagenic impurity. MDR Number MDR...
Class 2 Medicines Recall: Various Marketing Authorisation Holders and parallel distributor companies, Irbesartan-containing products, EL(21)A/34
Source: MHRA Gov.uk 30.11.21 Specific batches of products supplied by Marketing Authorisation Holders and parallel distributor companies are being recalled due to presence of a mutagenic impurity. MDR Number MDR...
Class 4 Medicines Defect Information: Mometasone Furoate 50 Microgram / Dose Nasal Spray, Suspension, PilsCo Ltd, EL (21)A/33
Source: MHRA Gov.uk 29.11.21 Error relating to the wording on the outer carton label for Mometasone Furoate 50 Microgram / Dose Nasal Spray, supplied by PilsCo Ltd. MDR Number...
Class 4 Medicines Defect Information: Diuril Oral Solution (unlicensed medicine), Mawdsley-Brooks & Company Limited, EL (21)A/32
Source: MHRA Gov.uk 29.11.21 Error with the patient information leaflet (PIL) that has been provided with Diuril Oral Solution, supplied by Mawdsley-Brooks & Company Limited. MDR Number MDR 241-11/21 Company...
Drug Tariff News – November Part VIIIA reimbursement prices (issued 26 November)
Source: NHSBSA The Department of Health and Social Care has agreed the November Drug Tariff Part VIIIA reimbursement prices for the following items: Amisulpride 50mg tablets 60 £2.99 Donepezil 1mg/ml oral solution...
Class 3 Medicines Recall: Martindale Pharma, an Ethypharm Group Company Methadone 5mg Tablets / Physeptone 5mg Tablets, EL (21)A/31
Source: MHRA/ Gov.uk 22.11.21 Martindale Pharma is recalling the below batch of Methadone 5mg tablets as a precautionary measure due to the discolouration of the PVdC film in a small...
Class 2 Medicines Recall: SANTEN Oy (trading as Santen UK Limited) and parallel distributor, IKERVIS 1 mg/mL eye drops, emulsion and VERKAZIA 1 mg/mL eye drops, emulsion, EL (21)A/30
Source: MHRA Gov.uk 18/11/21 SANTEN Oy (trading as Santen UK Limited) are recalling the above batches of products as a precautionary measure due to detection of particles/crystals of the active...
COVID-19 vaccination in children and young people aged 16 to 17 years: JCVI statement, November 2021
Source: DHSC/ Gov.uk 15 November 2021 This statement sets out further advice on the offer of second doses of COVID-19 vaccine to children and young people aged 16 to 17...
Class 4 Medicines Defect Information: Slenyto 1 mg and 5mg prolonged-release tablets – distributed by Flynn Pharma Ltd, EL (21)A/29
Source: MHRA / Gov.uk Flynn Pharma Ltd, distributors of Slenyto 1 mg and 5mg prolonged release tablets would like to notify you of an error with the patient information leaflets...
Investment and impact fund – inhaler prescribing
Source: NHSnetworks Four new indicators in the investment and impact fund (IIF) will support primary care teams in reducing carbon emissions from inhalers. Primary care networks (PCNs) are now rewarded...
Medicine Supply Notification: Xylocaine® 1% and 2% (lidocaine) with adrenaline 100micrograms/20ml solution for injection vials
Xylocaine® 1% and 2% (lidocaine) with adrenaline 100micrograms/20ml (1:200,000) solution for injection vials Tier 2 – medium impact* Date of issue: 8/11/2021 Link: https://www.sps.nhs.uk/shortages/shortage-of-lidocaine-adrenaline Summary • Xylocaine® 1% with adrenaline...
Medicines Supply Tool
Source: DHSC and NHSE/I Nov 2021 DHSC and NHSE/I in conjunction with the NHS Specialist Pharmacy Service have launched an online Medicines Supply Tool, which provides up to date information about...
